Home Cart Sign in  
Chemical Structure| 2169232-81-7 Chemical Structure| 2169232-81-7

Structure of Magrolimab
CAS No.: 2169232-81-7

Chemical Structure| 2169232-81-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Magrolimab is a humanized IgG4 monoclonal antibody that prevents CD47 from binding to Signal Regulatory Protein α (SIRPα). Magrolimab has potential for research in various cancers.

Synonyms: Hu5F9-G4

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Magrolimab

CAS No. :2169232-81-7
M.W : 145.74 kDa
SMILES Code : NONE
Synonyms :
Hu5F9-G4
MDL No. :N/A

Safety of Magrolimab

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02216409 Solid Tumor PHASE1 COMPLETED 2025-12-18 Stanford Cancer Institute, Sta... More >>nford, California, 94305, United States|University of Chicago, Chicago, Illinois, 60637, United States|START Midwest, Grand Rapids, Michigan, 49503, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, 10065, United States|University of Oklahoma, Oklahoma City, Oklahoma, 73104, United States|South Texas Accelerated Research Therapeutics, San Antonio, Texas, 78229, United States Less <<
NCT05169944 Brain Cancer|Malignant Brain T... More >>umor|Recurrent Brain Tumor|Progressive Malignant Brain Tumor|Brain Tumor, Pediatric|Brain Tumor Adult Less << PHASE1 COMPLETED 2024-09-30 University of California, San ... More >>Francisco, San Francisco, California, 94143, United States|Huntsman Cancer Institute, Salt Lake City, Utah, 84112, United States|University of Utah, Salt Lake City, Utah, 84113, United States Less <<
NCT05627466 Relapsed/Refractory Acute Myel... More >>oid Leukemia Less << NO_LONGER_AVAILABLE - -
NCT02678338 Acute Myeloid Leukemia|Myelody... More >>splastic Syndrome Less << PHASE1 COMPLETED 2025-02-19 University Hospital of Wales, ... More >>Cardiff, United Kingdom|St. James University Hospital, Leeds, United Kingdom|The Royal Liverpool University Hospital, Liverpool, United Kingdom|The Christie NHS Foundation Trust, Manchester, United Kingdom|Churchill Hospital, Oxford, United Kingdom Less <<
 

Historical Records

Categories